FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV

FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV

Submitted by admin on June 8, 2023 - 9:47pm
Source: 
Stat
News Tags: 
AstraZeneca
RSV
FDA
monoclonal antibodies
pediatric
Beyfortus
Headline: 
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
snippet: 

A Food and Drug Administration advisory committee voted overwhelmingly on Thursday to recommend approval of a monoclonal antibody product to protect newborns and young children from RSV.

Do Not Allow Advertisers to Use My Personal information